ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the Fiscal Year ending January 2, 2010. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.03 per share for the one year period ended January 2, 2010. As of January 2, 2010, cash, cash equivalents, and marketable securities totaled $471,378.
"2009 was a strong year for ChromaDex as we continued to grow our core business," said Frank Jaksch, CEO and co-founder of ChromaDex. "Going into 2010, we feel that our product and service offerings will be in greater demand as the economy recovers and food, beverage, personal care and nutrition companies increase their focus on natural products and green chemistry."
Additional Financial Results & Notes
On a reported basis, ChromaDex recorded revenue during 2009 of $5,777,865 as compared to $4,506,301 in 2008. The net loss attributable to common stockholders for the year ending January 2, 2010, was $907,568 as compared to a net loss of $2,104,476 in 2008. The lower net loss in 2009 as compared to the same period in 2008 was due to [non-recurring] expenses in 2008 related to the reverse merger acquisition of Cody Resources, Inc. coupled with an increase in revenues. The Company notes that as a result of its closing of the reverse merger acquisition of Cody Resources, Inc. on June 20, 2008, investors are cautioned that the Company's historical performance for that year is not directly comparable.
New research explores how omega-3 and omega-6 fatty acids may impact cancer rates